Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Johnson & Johnson

NYSE: JNJHealthcare / Drug Manufacturers - Major / USA
147.10+0.60+0.41%Vol 8 725 5151Y Perf 3.48%
Dec 12th, 2018 16:01
BID147.19 ASK147.20
Open147.00 Previous Close146.50
Pre-Market147.24 After-Trading147.10
 0.74 0.51%  - -%
Target Price
148.31 
Analyst Rating
Moderate Buy 2.17
Potencial %
0.82 
Finscreener Ranking
     33.51
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
+     35.65
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★+     39.09
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
★★     41.41
Market Cap (mil)394 655 
Earnings Rating
Buy
Price Range Ratio 52wk %
93.78 
Earnings Date
22nd Jan 2019

Today's Price Range

147.00148.49

52wk Range

118.62148.99

5 Year PE Ratio Range

14.3024.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
0.60%
3 Months
5.12%
6 Months
19.55%
1 Year
3.48%
3 Years
45.12%
5 Years
70.06%

Quotes

Name / TickerPriceChg.Chg.%
JNJ147.100.60000.41
AAPL169.100.47000.28
GOOG1 063.6811.93001.13
MSFT109.080.49000.45
XOM76.02-0.6600-0.86
WFC47.74-0.0200-0.04
FB144.502.42001.70
GE6.71-0.0500-0.74
JPM101.020.65000.65
 
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.20
Current Ratio
1.70
Long Term Debt to Total Capital
0.31
Total Debt to Equity
0.48
Interest Coverage
17.90
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
66.40
EBIT Margin
22.70
EBITDA Margin
31.40
Pre-tax Profit Margin
25.50
Profit Margin
1.89
ValuationValueIndustryS&P 500US Markets
PE Ratio
246.50
PB Ratio
6.04
PS Ratios
4.79
Price to Cash Flow
18.00
Price to Free Cash Flow
40.10
Cash Flow Per Share
8.07
Price to Tangible Book
-26.51
Book Value per Share
24.10
Enterprise Value (in ths.)
401 929 000
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
18.23
ROE last 12 Months
2.23
Return on Assets (5Y Avg)
8.15
ROA last 12 Months
0.99
Return on Capital (5Y Avg)
14.33
ROC last 12 Months
1.56
Return on invested Capital Q
4.17
Return on invested Capital Y
1.39
Assets Turnover
0.20
Receivables Turnover
2.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
81 382 000
Revenue per Share
30.34
Revenue Growth 3 Years
4.48
Revenue Growth 5 Years
1.96
DividendsValueIndustryS&P 500US Markets
Dividend Yield
2.48
Dividend Rate
3.60
Dividend Growth 3 Years
5.33
Dividend Growth 5 Years
6.05

Earnings HistoryEstimateReportedSurprise %
Q03 20182.032.050.99
Q02 20182.062.101.94
Q01 20182.012.062.49
Q04 20171.721.741.16
Q03 20171.801.905.56
Q02 20171.791.832.23
Q01 20171.771.833.39
Q04 20161.561.581.28
Earnings Per EndEstimateRevision %Trend
12/2018 QR1.951.04Positive
12/2018 FY8.160.25Positive
3/2019 QR2.17-0.91Negative
12/2019 FY8.660.12Positive
Next Report Date22nd Jan 2019
Estimated EPS Next Report1.95
Estimates Count7
EPS Growth Next 5 Years %7.80
Volume Overview
Volume8 725 515
Shares Outstanding (in ths.)2 682 900
Trades Count39 494
Dollar Volume1 095 791 094
Avg. Volume7 110 143
Avg. Weekly Volume8 900 082
Avg. Monthly Volume8 243 136
Avg. Quarterly Volume7 348 817

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

49%51%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (33.33 %)
4 (33.33 %)
7 (43.75 %)
Moderate Buy
2 (16.67 %)
2 (16.67 %)
2 (12.50 %)
Hold
6 (50.00 %)
6 (50.00 %)
7 (43.75 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.17
Moderate Buy
2.17
Moderate Buy
2.00

There are no comments yet.

News